Skip to main content
. 2022 Jun 28;13:918493. doi: 10.3389/fphar.2022.918493

TABLE 2.

Overall Costs of PGx-testing, pharmacist and physician time for interpretation and drug treatment.

Drug N drug Initiators Cost of PGx Test/€ per Initiator Average Cost of HCP Interpretation of Actionable PGx Result/€ per Initiator a Average Cost of Drugs for Standard of Care (SoC) Treatment/€ per Initiator in 1 year Average Cost of Drugs for PGx-Guided Treatment/€ per Initiator in 1 year Difference in Average Drug Costs b (SoC-PGx) (% Saved)/€ per Initiator in 1 year Total Costs for all initiators c /€
Azathioprine 6,979 132 1 248 237 11 (4.6%) 854,659
Capecitabine 8,860 132 1 1,204 1,158 46 (3.9%) 775,246
Clopidogrel 117,900 132 5 15 38 −24 (−62%) 18,923,430
Fluorouracil (systemic) 6,765 132 1 82 79 3 (4.0%) 880,112
Irinotecan 2,593 66 2 14,842 14,588 253 (1.7%) -481,019
Mercaptopurine 2,177 132 1 1,956 1,875 81 (4.3%) 114,172
Tioguanine 2,854 132 1 1,088 1,080 7 (0.7%) 359,471
TOTAL for all initiators/€ 148,128 19,381,790 586,167 60,519,056 61,977,169 −1,458,113 21,426,070
Mean per initiator/€ - 131 16 a 409 418 10 145

PGx, pharmacogenomic.

a

Note: only those with an actionable drug-gene interaction will be interpreted by an HCP.

b

[cost drugsstandard of care]-[cost drugsPGx-guided]*[Ndrug initiators].

c

[costPGxtest]+[costpharmacist and physician time]-[costdrugs].